Form 4 for IBRX ImmunityBio, Inc.
Accepted 2026-04-02 20:08:43 ET · period of report 2026-03-31 · accession 0001189020-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-04-02 20:08 | 2026-03-31 | IBRX | SOON-SHIONG PATRICK | See remarks, Dir, 10% | C - Cnv Deriv | $5.43 | +4.61M | 251.02M | +2% | +$25.00M |
| DI | 2026-04-02 20:08 | 2026-03-31 | IBRX | SOON-SHIONG PATRICK | See remarks, Dir, 10% | C - Cnv Deriv | — | 0 | 480.00M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | C | A | 4,606,596 | $5.43 | 251,018,873 | I See footnote | — | — | (F1) Shares held by Nant Capital, LLC, an investment vehicle of the Reporting Person. |
| 2 | Derivative | Second Amended and Restated Convertible Promissory Note | 2026-03-31 | C | D | — | $0.00 | 480,000,000 | I See footnote | $5.43 · 2024-12-10 to 2027-12-31 | — Common Stock | (F9) Nant Capital has the right at any time after December 10, 2024 and on or before December 31, 2027 to convert all or a portion of the outstanding principal amount of this Second Amended and Restated Promissory Note, as amended January 23, 2026, into fully paid and nonassessable shares of the Issuer's common stock at a price per share equal to $5.427. On March 31, 2026, Nant Capital delivered notice to the Issuer electing to convert outstanding principal in the amount of $25,000,000 into 4,606,596 shares of the Issuer's common stock. (F9) Nant Capital has the right at any time after December 10, 2024 and on or before December 31, 2027 to convert all or a portion of the outstanding principal amount of this Second Amended and Restated Promissory Note, as amended January 23, 2026, into fully paid and nonassessable shares of the Issuer's common stock at a price per share equal to $5.427. On March 31, 2026, Nant Capital delivered notice to the Issuer electing to convert outstanding principal in the amount of $25,000,000 into 4,606,596 shares of the Issuer's common stock. (F1) Shares held by Nant Capital, LLC, an investment vehicle of the Reporting Person. |